XML 151 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Changes In Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
 [1]
Common Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
 [1]
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2022     16,094,486            
Beginning balance at Dec. 31, 2022 $ 512,099 $ (11,548) $ 16,094   $ 386,987 $ 133,114 $ (11,548) $ (19,216) $ (4,880)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income available to common shareholders 37,397         37,397      
Total other comprehensive (loss) income, net of taxes 2,579             2,579  
Common stock cash dividends declared (12,981)         (12,981)      
Common stock issued to shareholders in acquisition (in shares) [2]     849,510            
Common stock issued to shareholders in acquisition [2] 18,095   $ 850   17,245        
Repurchased stock (4,876)       (37)       (4,839)
Employee Stock Purchase Plan (in shares)     13,459            
Employee Stock Purchase Plan 303   $ 13   290        
Director Stock Purchase Plan (in shares)     7,884            
Director Stock Purchase Plan 179   $ 8   171        
Restricted stock activity (in shares)     33,590            
Restricted stock activity 1,103     $ 34 1,069        
Ending balance (in shares) at Dec. 31, 2023     16,998,929            
Ending balance at Dec. 31, 2023 542,350   $ 16,999   405,725 145,982   (16,637) (9,719)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income available to common shareholders 49,437         49,437      
Total other comprehensive (loss) income, net of taxes (188)             (188)  
Common stock cash dividends declared (13,822)         (13,822)      
Common stock issued to shareholders in acquisition (in shares) [3]     2,731,250            
Common stock issued to shareholders in acquisition [3] 75,956   $ 2,731   73,225        
Repurchased stock [4] (323)               (323)
Employee Stock Purchase Plan (in shares)     19,829            
Employee Stock Purchase Plan 438   $ 20   418        
Director Stock Purchase Plan (in shares)     5,072            
Director Stock Purchase Plan 123   $ 5   118        
Restricted stock activity (in shares)     41,439            
Restricted stock activity $ 1,047     42 1,005        
Ending balance (in shares) at Dec. 31, 2024 19,355,797   19,796,519            
Ending balance at Dec. 31, 2024 $ 655,018   $ 19,797   480,491 181,597   (16,825) (10,042)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income available to common shareholders 56,248         56,248      
Total other comprehensive (loss) income, net of taxes 10,502             10,502  
Common stock cash dividends declared (18,160)         (18,160)      
Common stock issued to shareholders in acquisition (in shares) [5]     3,506,795            
Common stock issued to shareholders in acquisition [5] 103,206   $ 3,507   99,699        
Stock options exercised (in shares)     147,946            
Stock options exercised 6,876   $ 148   6,728        
Repurchased stock [4] (2,250)               (2,250)
Employee Stock Purchase Plan (in shares)     19,008            
Employee Stock Purchase Plan 516   $ 19   497        
Director Stock Purchase Plan (in shares)     3,600            
Director Stock Purchase Plan 103   $ 4   99        
Restricted stock activity (in shares)     93,226            
Restricted stock activity $ 1,999     $ 92 1,907        
Ending balance (in shares) at Dec. 31, 2025 23,047,203   23,567,094            
Ending balance at Dec. 31, 2025 $ 814,058   $ 23,567   $ 589,421 $ 219,685   $ (6,323) $ (12,292)
[1] The Corporation adopted ASC 326, Financial Instruments - Credit Losses, effective January 1, 2023. See "Note 1 - Summary of Significant Accounting Policies" for further details.
[2] Shares issued as a result of the acquisition of Brunswick Bancorp ("Brunswick").
[3] Shares issued as a result of the underwritten public offering of 2,375,000 shares of common stock at a price of $29.50 per share on November 4, 2024.
[4] Includes tax effects of repurchased stock.
[5] Shares issued on April 30, 2025 as a result of the William Penn Acquisition. See "Note 2 - Business Combinations" to the Consolidated Financial Statements for more information.